NCT05710562Completed
Epidemiological Description of Health Determinants in Italian Anticoagulated Population
Epidemiological Description of Health Determinants in Italian Anticoagulated Population (EDIA): a Cross-sectional and Multicenter Study Design
Source: ClinicalTrials.gov · Last updated 8 May 2026
Brief summary (registry, in English)
The primary aim of this study is to describe and develop a cross-sectional profile of the level of the main health determinants in the Italian anticoagulated population (disease knowledge; self-efficacy; health literacy; quality of life). Indeed, evaluate how socio-demographic and clinical data may affect the same relations. Furthermore, the secondary aim is to describe relationships between health determinants and anticoagulation control (i.e., Time in Therapeutic Range, TTR%, or absence of clinical complications). To evaluate the impact of socio-demographic and clinical data on the relationship between health determinants and anticoagulation control.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 468 (actual)
- First submitted
- 24 Jan 2023
- Start date
- 5 Feb 2019
- Primary completion date
- 5 Feb 2025
- Lead sponsor
- IRCCS Policlinico S. Donato
- Diseases
- Atrial fibrillation
- NCT number
- NCT05710562
What you commit to
- Study type: Observational
- Participants enrolled: 468
- From 5 Feb 2019 to the primary completion date, 5 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients treated with oral anticoagulant therapy for a brief period (i.e., treatment \< 6 months)
- Patients who have suspended oral anticoagulation therapy for surgery in the last three months
Other illness
- Cognitive impairment (assessed using a six-item screener)
Other
- Patients with severe comorbidity (i.e., Charlson Comorbidity Index, ICC \> 4)
Who the study is looking for
- Age greater or equal to18 years
- Outpatients
- Patients treated with oral anticoagulation therapy for at least three mounts
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Policlinico San Donato Coordinator of this site? Confirm its status | San Donato Milanese | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.